ポストバイオティクス市場：製品タイプ、製剤、機能性、包装タイプ、用途、エンドユーザー、流通チャネル別-2025-2030年世界予測

ポストバイオティクス市場の2024年の市場規模は16億2,000万米ドルで、2025年には17億4,000万米ドル、CAGR 7.41%で成長し、2030年には25億米ドルに達すると予測されています。

近年、生物活性成分の世界は根本的な再構築を経験し、ポストバイオティクスが健康とウェルネス向上の探求における重要な原動力として浮上しています。本市場エグゼクティブサマリーでは、進化するポストバイオティクスの力学を深く掘り下げ、イノベーション、消費者の健康に対する要望、革新的な科学研究の間の複雑なバランスを浮き彫りにします。製品開発における画期的な動向、急速に変化する消費者の嗜好、食生活の機能性に関する研究結果の広範な意味合いなど、幅広い範囲にわたって解説しています。

ポストバイオティクス市場は、ニッチセグメントとしてだけでなく、消化器系の健康から免疫サポートに至るまで、変化をもたらす強力な触媒としてますます認識されるようになっています。この分野における科学の進化は、品質と天然の効能に焦点を当てながら、的を絞った効能を提供する新世代の製品への道を開いています。本書は、市場細分化、地域動向、主要企業、戦略的提言など、新たなビジネスチャンスの獲得を目指す利害関係者にとって不可欠な洞察を提供する構成となっています。

アナリスト、イノベーター、意思決定者は、本書の分析が市場状況、主要成長促進要因・課題に関する多角的な評価を反映していることに気づくと思われます。その目的は、ますます競合が激化するダイナミックな環境において、読者が十分な情報に基づいた意思決定を行うために必要な情報を提供する、包括的でバランスの取れた概観を提供することです。

ポストバイオティクスの情勢を再定義する転換期

ポストバイオティクス市場は、科学研究の進歩、消費者の需要の進化、革新的な製品開発によって、激変を経験しています。こうした変化は、従来のプロバイオティクスから、より安定的で強力なポストバイオティクス製剤へと焦点を移しただけでなく、健康増進製品を日常生活にどのように取り入れるかの再評価にもつながっています。

注目すべき変革には、ポストバイオティクスが免疫反応や消化機能性を調節するメカニズムだけでなく、宿主と微生物の相互作用についての理解を深めるための研究投資の増加が含まれます。最新の生産技術により、ポストバイオティクスの安定性と生物学的利用能が改善され、生きた微生物に関連する保存上の課題なしに有効性を確保できる製剤が生み出されるようになりました。

同時に、消費者の教育と意識向上が需要を牽引する上で極めて重要な役割を果たしています。より多くの情報を持つ消費者は、科学的データによって実証された製品を積極的に求め、その結果、市場は透明性と根拠に基づく主張を重視するようになりました。このような先進的な環境により、ポストバイオティクスは脚光を浴びるようになり、機能性製剤の成分として好まれるようになりました。

市場の成熟が進むにつれて、企業は新規のデリバリーシステムと強化された製剤技術の統合に向けたアプローチを再重点化しています。規制の枠組みが科学的な理解により合致するようになったことで、企業はこうした変革的なシフトを活用してイノベーションを起こし、事業を拡大し、最終的には世界中の健康志向の消費者に支持される製品を提供する態勢を整えています。

主要セグメンテーションと市場戦略への影響

ポストバイオティクス市場のきめ細かなセグメンテーションは、消費者ニーズと製品機能の微妙な理解を浮き彫りにしています。分析によると、さまざまな属性によってセグメント化された多様な製品ポートフォリオがあり、それぞれが明確な形で市場に影響を与えています。まず製品タイプから見ていくと、市場はカプセル、液体、粉末、錠剤で調査されています。さらに細分化すると、液剤は濃縮液剤とすぐに飲める製剤に分けられ、錠剤はチュアブルタイプと発泡タイプに細分化されます。このような詳細なセグメンテーションにより、微妙な消費者の嗜好を正確に捉えることができます。

さらに、製剤ベースのセグメンテーションは、カプセル化された製品とカプセル化されていない製品の重要性を浮き彫りにし、有効成分と同様に送達メカニズムも重要であることを強調しています。消化器系の健康、免疫サポート、皮膚の健康、体重管理など、機能性の次元は、目標とするベネフィットをさらに明確にし、製品の保証を消費者の具体的な目標と一致させる。

パッケージもまた重要な役割を果たしており、市場はボトル、小袋、スティックパックのレンズを通して分析されます。ボトルはさらにガラス製とプラスチック製に分類され、小袋は複数回用と1回用があります。このようなセグメンテーションは、効能を維持し、使いやすさを確保するための最適なパッケージング・ソリューションを特定するのに役立ちます。

用途に基づく洞察は、動物飼料、飲食品、パーソナルケア、医薬品（後者は医薬品製剤とプロバイオティクス・サプリメントに分類）などのセクターにわたる分析から得られます。これは、業界を超えたポストバイオティクス製剤の多用途性と堅牢性を示しています。さらに、成人、老年、小児を含むエンドユーザー区分は、栄養ニーズと消費パターンの違いを浮き彫りにしています。最後に、流通チャネルを調べることで、市場はeコマース、薬局・薬店、専門店、スーパーマーケット・ハイパーマーケットに分類され、eコマースはeコマースサイトと定期購入サービスに、専門店は栄養補助食品店と健康食品店に区別されます。スーパーマーケットとハイパーマーケットのセグメントは、さらに一般的なセクションとオーガニック健康セクションに分かれています。このセグメンテーションを総合すると、包括的な見解が得られ、利害関係者は的確にターゲットを絞り、戦略を調整することができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腸の健康とそれが全体的な健康に与える影響に対する消費者の意識の高まり
    • 世界中で天然成分や機能性成分への嗜好が高まっている
  • 抑制要因
    • 高い製造コストとポストバイオティクスの商業的入手の制限に関する懸念
  • 機会
    • 製薬会社と提携し、消化器系の健康のためのポストバイオティクス製剤を開発
    • 革新的な化粧品を求める消費者を引き付けるために、スキンケアにポストバイオティクスを組み込む
  • 課題
    • 規制上のハードルを理解し、市場の承認を得ることは、ポストバイオティクスにとって重要な課題です。
• 市場セグメンテーション分析
  • 製品タイプ：利便性と正確な投与量のため、カプセルが好まれる
  • 応用：自己治療の動向と予防ヘルスケアのアプローチの増加により、プロバイオティクスサプリメントの使用が増加しています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 ポストバイオティクス市場：製品タイプ別

• カプセル
• 液体
  • 濃縮液体
  • そのまま飲める液体
• 粉末
• タブレット
  • チュアブル錠
  • 発泡錠

第7章 ポストバイオティクス市場処方別

• カプセル化
• カプセル化されていない

第8章 ポストバイオティクス市場機能別

• 消化器系の健康
• 免疫サポート
• 肌の健康
• 体重管理

第9章 ポストバイオティクス市場：パッケージングタイプ別

• ボトル
  • ガラス瓶
  • ペットボトル
• サシェ
  • マルチサービングサシェ
  • 使い捨てサシェ
• スティックパック

第10章 ポストバイオティクス市場：用途別

• 動物飼料
• 食品・飲料
• パーソナルケア
• 医薬品
  • 医薬品製剤
  • プロバイオティクスサプリメント

第11章 ポストバイオティクス市場：エンドユーザー別

• 大人
• 老年医学
• 小児科

第12章 ポストバイオティクス市場：流通チャネル別

• オンラインストア
  • Eコマースウェブサイト
  • サブスクリプションサービス
• 薬局・ドラッグストア
• 専門店
  • 栄養補助食品店
  • 健康食品店
• スーパーマーケットとハイパーマーケット
  • 一般健康セクション
  • オーガニック健康セクション

第13章 南北アメリカのポストバイオティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域のポストバイオティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカのポストバイオティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Archer-Daniels-Midland Company
• Beekeeper's Naturals, Inc.
• Bioflag Group
• Cargill Incorporated
• Dr. Emil Nutrition, LLC
• DSM-Firmenich AG
• Essential Formulas Incorporated
• GeneFerm Biotechnology Co., Ltd.
• Gundry MD
• GutArmor by Get Wellness, LLC
• Healist Naturals, LLC
• Ildong Pharmaceutical Co., Ltd.
• Kerry Group PLC
• Kirin Holdings Company, Limited
• L'Oreal S.A.
• Maypro Group
• MCLS Europe B.V.
• MRM Nutrition
• Otemchi Biotechnologies Pte. Ltd.
• Phileo by Lesaffre
• Postbiotics Inc.
• Probiotics Australia Pty., Ltd.
• Probioway Co., Ltd.
• Puratos Group
• Sabinsa Corporation
• Silab SA
• woresan GmbH
• POSTBIOTICA S.R.L.

LIST OF FIGURES

• FIGURE 1. POSTBIOTICS MARKET MULTI-CURRENCY
• FIGURE 2. POSTBIOTICS MARKET MULTI-LANGUAGE
• FIGURE 3. POSTBIOTICS MARKET RESEARCH PROCESS
• FIGURE 4. POSTBIOTICS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 21. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 25. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 29. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 30. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 31. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. POSTBIOTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POSTBIOTICS MARKET DYNAMICS
• TABLE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY CONCENTRATED LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY READY-TO-DRINK LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POSTBIOTICS MARKET SIZE, BY EFFERVESCENT TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POSTBIOTICS MARKET SIZE, BY ENCAPSULATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL POSTBIOTICS MARKET SIZE, BY UNENCAPSULATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL POSTBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL POSTBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL POSTBIOTICS MARKET SIZE, BY SKIN HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL POSTBIOTICS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL POSTBIOTICS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL POSTBIOTICS MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL POSTBIOTICS MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL POSTBIOTICS MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL POSTBIOTICS MARKET SIZE, BY MULTI-SERVING SACHETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL POSTBIOTICS MARKET SIZE, BY SINGLE USE SACHETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL POSTBIOTICS MARKET SIZE, BY STICK PACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL POSTBIOTICS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL POSTBIOTICS MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL POSTBIOTICS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL POSTBIOTICS MARKET SIZE, BY MEDICINE DRUG FORMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL POSTBIOTICS MARKET SIZE, BY PROBIOTIC SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL POSTBIOTICS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL POSTBIOTICS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL POSTBIOTICS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL POSTBIOTICS MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL POSTBIOTICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL POSTBIOTICS MARKET SIZE, BY DIETARY SUPPLEMENT STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL POSTBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL POSTBIOTICS MARKET SIZE, BY GENERAL HEALTH SECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL POSTBIOTICS MARKET SIZE, BY ORGANIC HEALTH SECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. ARGENTINA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 91. ARGENTINA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 92. ARGENTINA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 101. BRAZIL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. BRAZIL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 103. BRAZIL POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. BRAZIL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. BRAZIL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 106. BRAZIL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 107. BRAZIL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 108. CANADA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. CANADA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 110. CANADA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 111. CANADA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 112. CANADA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 113. CANADA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 114. CANADA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 115. CANADA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 116. CANADA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. CANADA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 118. CANADA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. CANADA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. CANADA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 121. CANADA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 122. CANADA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 123. MEXICO POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. MEXICO POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 125. MEXICO POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 126. MEXICO POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 127. MEXICO POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 128. MEXICO POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 129. MEXICO POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 130. MEXICO POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 131. MEXICO POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. MEXICO POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 133. MEXICO POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. MEXICO POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. MEXICO POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 136. MEXICO POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 137. MEXICO POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 138. UNITED STATES POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED STATES POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED STATES POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED STATES POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED STATES POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED STATES POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED STATES POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 145. UNITED STATES POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 146. UNITED STATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED STATES POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 148. UNITED STATES POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. UNITED STATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. UNITED STATES POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 151. UNITED STATES POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 152. UNITED STATES POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 153. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 154. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 156. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 158. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 159. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 161. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 162. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 164. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 168. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 170. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. AUSTRALIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 172. AUSTRALIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 173. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 174. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 175. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 176. AUSTRALIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 177. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 178. AUSTRALIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 180. AUSTRALIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. AUSTRALIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. AUSTRALIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 183. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 184. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 185. CHINA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. CHINA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 187. CHINA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 188. CHINA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 189. CHINA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 190. CHINA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 191. CHINA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 192. CHINA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 193. CHINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. CHINA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 195. CHINA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. CHINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. CHINA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 198. CHINA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 199. CHINA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 200. INDIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. INDIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 202. INDIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 203. INDIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 204. INDIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 205. INDIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 206. INDIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 207. INDIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 208. INDIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. INDIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 210. INDIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. INDIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. INDIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 213. INDIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 214. INDIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 215. INDONESIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. INDONESIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 217. INDONESIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 218. INDONESIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 219. INDONESIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 220. INDONESIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 221. INDONESIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 222. INDONESIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 223. INDONESIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. INDONESIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 225. INDONESIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. INDONESIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. INDONESIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 228. INDONESIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 229. INDONESIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 230. JAPAN POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. JAPAN POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 232. JAPAN POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 233. JAPAN POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 234. JAPAN POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 235. JAPAN POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 236. JAPAN POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 237. JAPAN POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 238. JAPAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. JAPAN POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 240. JAPAN POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. JAPAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. JAPAN POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 243. JAPAN POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 244. JAPAN POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 245. MALAYSIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. MALAYSIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 247. MALAYSIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 248. MALAYSIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 249. MALAYSIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 250. MALAYSIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 251. MALAYSIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 252. MALAYSIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 253. MALAYSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. MALAYSIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 255. MALAYSIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 256. MALAYSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 257. MALAYSIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 258. MALAYSIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 259. MALAYSIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 260. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 261. PHILIPPINES POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 262. PHILIPPINES POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 263. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 264. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 265. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 266. PHILIPPINES POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 267. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 268. PHILIPPINES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 270. PHILIPPINES POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. PHILIPPINES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. PHILIPPINES POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 273. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 274. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 275. SINGAPORE POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 276. SINGAPORE POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 277. SINGAPORE POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 278. SINGAPORE POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 279. SINGAPORE POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 280. SINGAPORE POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SINGAPORE POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 282. SINGAPORE POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 283. SINGAPORE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 284. SINGAPORE POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 285. SINGAPORE POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 286. SINGAPORE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 287. SINGAPORE POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 288. SINGAPORE POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 289. SINGAPORE POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 290. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 292. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 294. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 297. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 298. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 300. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 301. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 302. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 303. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 304. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 305. TAIWAN POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 306. TAIWAN POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 307. TAIWAN POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 308. TAIWAN POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 309. TAIWAN POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 310. TAIWAN POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 311. TAIWAN POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 312. TAIWAN POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 313. TAIWAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 314. TAIWAN POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 315. TAIWAN POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. TAIWAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 317. TAIWAN POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 318. TAIWAN POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 319. TAIWAN POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 320. THAILAND POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 321. THAILAND POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 322. THAILAND POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 323. THAILAND POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 324. THAILAND POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 325. THAILAND POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 326. THAILAND POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 327. THAILAND POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 328. THAILAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 329. THAILAND POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 330. THAILAND POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 331. THAILAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 332. THAILAND POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 333. THAILAND POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 334. THAILAND POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 335. VIETNAM POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 336. VIETNAM POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 337. VIETNAM POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 338. VIETNAM POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 339. VIETNAM POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 340. VIETNAM POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 341. VIETNAM POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 342. VIETNAM POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 343. VIETNAM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 344. VIETNAM POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 345. VIETNAM POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 346. VIETNAM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 347. VIETNAM POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 348. VIETNAM POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 349. VIETNAM POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 350. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 351. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 352. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 353. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 354. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 355. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 356. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 357. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
• TABLE 358. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 359. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 360. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 361. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 362. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
• TABLE 363. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
• TABLE 364. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
• TABLE 365. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 366. DENMARK POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 367. DENMARK POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
• TABLE 368. DENMARK POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
• TABLE 369. DENMARK POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 370. DENMARK POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 371. DENMARK POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 372. DENMARK POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
• TABLE 373. DENMARK POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)

TABL

The Postbiotics Market was valued at USD 1.62 billion in 2024 and is projected to grow to USD 1.74 billion in 2025, with a CAGR of 7.41%, reaching USD 2.50 billion by 2030.

In recent years, the world of bioactive ingredients has experienced a radical re-imagining, with postbiotics emerging as a key driver in the quest for improved health and wellness. This market executive summary provides a deep dive into the evolving dynamics of postbiotics, highlighting the intricate balance between innovation, consumer health demands, and transformative scientific research. The narrative spans a spectrum that encompasses breakthrough trends in product development, rapidly changing consumer preferences, and the broader implications of research findings on dietary functionalities.

The postbiotics market is increasingly being recognized not only as a niche segment but as a robust catalyst for change in areas ranging from digestive health to immune support. The evolution of science in this field has paved the way for a new generation of products that offer targeted benefits while maintaining a focus on quality and natural efficacy. This document is structured to offer insights into market segmentation, regional trends, leading companies, and strategic recommendations that are essential for stakeholders aiming to capitalize on emerging opportunities.

Analysts, innovators, and decision-makers will find that the analysis herein reflects a multifaceted evaluation of market conditions, key growth drivers, and potential challenges. The aim is to provide a comprehensive and balanced overview that equips readers with the intelligence needed to make informed decisions in an increasingly competitive and dynamic environment.

Transformative Shifts Redefining the Postbiotics Landscape

The postbiotics market has experienced seismic shifts propelled by advancements in scientific research, evolving consumer demands, and innovative product development. These changes have not only shifted the focus from traditional probiotics to more stable, potent postbiotic formulations but have also led to a reassessment of how health-enhancing products are incorporated into everyday lifestyles.

Notable transformations include increased research investments that have refined our understanding of host-microbe interactions as well as the mechanisms by which postbiotics modulate immune responses and digestive functionalities. Modern production techniques have improved the stability and bioavailability of postbiotics, resulting in formulations that ensure efficacy without the storage challenges associated with live microorganisms.

Concurrently, consumer education and awareness have played a pivotal role in driving demand. More informed consumers actively seek products that are substantiated by scientific data, resulting in a market that values transparency and evidence-based claims. This progressive environment has catapulted postbiotics into the limelight, making them a preferred component in functional formulations.

As the market continues to mature, businesses have refocused their approach toward integrating novel delivery systems and enhanced formulation technologies. With regulatory frameworks now better aligned with scientific understandings, companies are poised to leverage these transformative shifts to innovate, scale operations, and ultimately offer products that resonate with health-conscious consumers worldwide.

Key Segmentation and Its Impact on Market Strategy

The granular segmentation of the postbiotics market underscores a nuanced understanding of consumer needs and product functionalities. Analysis reveals a diverse product portfolio segmented by various attributes, each impacting the market in distinct ways. Start with the product type, where the market is studied across capsules, liquids, powders, and tablets. Further disaggregation sees the liquids split into concentrated liquids and ready-to-drink formulations, while tablets are refined into chewable and effervescent formats. Such detailed segmentation ensures that nuanced consumer preferences are captured with precision.

In addition, formulation-based segmentation highlights the importance of encapsulated versus unencapsulated products, emphasizing that the delivery mechanism is as critical as the active ingredient. The functionality dimension-spanning digestive health, immune support, skin health, and weight management-further delineates targeted benefits, aligning product assurances with specific consumer goals.

Packaging also plays a crucial role, with the market being analyzed through the lens of bottles, sachets, and stick packs. Bottles can be further classified as glass or plastic, while sachets vary between multi-serving and single-use options. Such segmentation assists in identifying the best packaging solutions to preserve efficacy and ensure ease of use.

Application-based insights are derived from analysis across sectors such as animal feed, food and beverages, personal care, and pharmaceuticals, the latter dissected into medicine drug formulation and probiotic supplements. This showcases the versatility and robustness of postbiotic formulations across industries. Furthermore, end-user segmentation, including adults, geriatrics, and pediatrics, highlights varying nutritional needs and consumption patterns. Lastly, by examining the distribution channel, the market looks at online stores, pharmacies and drug stores, specialty stores, and supermarkets and hypermarkets, with online stores further categorized into e-commerce websites and subscription services, and specialty stores distinguishing between dietary supplement and health food stores. The supermarkets and hypermarkets segment is split further into general and organic health sections. Collectively, the segmentation offers a comprehensive view that enables stakeholders to target and tailor their strategies with accuracy.

Based on Product Type, market is studied across Capsules, Liquids, Powders, and Tablets. The Liquids is further studied across Concentrated Liquids and Ready-To-Drink Liquids. The Tablets is further studied across Chewable Tablets and Effervescent Tablets.

Based on Formulation, market is studied across Encapsulated and Unencapsulated.

Based on Functionality, market is studied across Digestive Health, Immune Support, Skin Health, and Weight Management.

Based on Packaging Type, market is studied across Bottles, Sachets, and Stick Packs. The Bottles is further studied across Glass Bottles and Plastic Bottles. The Sachets is further studied across Multi-Serving Sachets and Single Use Sachets.

Based on Application, market is studied across Animal Feed, Food & Beverages, Personal Care, and Pharmaceuticals. The Pharmaceuticals is further studied across Medicine Drug Formulation and Probiotic Supplements.

Based on End-User, market is studied across Adults, Geriatrics, and Pediatrics.

Based on Distribution Channel, market is studied across Online Stores, Pharmacies & Drug Stores, Specialty Stores, and Supermarkets & Hypermarkets. The Online Stores is further studied across E-commerce Websites and Subscription Services. The Specialty Stores is further studied across Dietary Supplement Stores and Health Food Stores. The Supermarkets & Hypermarkets is further studied across General Health Sections and Organic Health Sections.

Regional Dynamics Shaping the Postbiotics Market

The postbiotics market exhibits a compelling regional variation, with key insights emerging from major global areas. In the Americas, innovations in product development and increasing consumer focus on digestive and overall well-being have created fertile ground for the adoption of postbiotics. This region benefits from robust research and an innovative milieu that supports swift regulatory adaptations, facilitating the introduction of groundbreaking products.

In the combined region of Europe, the Middle East and Africa, a blend of traditional health practices alongside modern scientific insights has contributed to a growing affinity for postbiotics. Here, there is a concerted effort to merge conventional wisdom with state-of-the-art research, resulting in products that cater to diverse consumer segments while adhering to stringent quality standards.

The Asia-Pacific region stands out for its dynamic regulatory environments and rapid economic growth, driving an expanding market presence for health-enhancing ingredients. With a rising middle class and an increasing emphasis on wellness, the unique consumer behaviors in this region have spurred a variety of postbiotic offerings, accommodating both novel formulations and traditional approaches.

Understanding these regional dynamics is essential as they provide a framework within which global strategies can be localized, ensuring products are effectively aligned with consumer expectations and regulatory landscapes in each geographic area.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders and Their Strategic Footprints

The competitive landscape is defined by a cadre of influential companies that have each contributed to evolving the postbiotics narrative. Established industry leaders such as Archer-Daniels-Midland Company and Cargill Incorporated have harnessed vast networks and substantial research capabilities to capitalize on this rapidly expanding segment. Emerging players like Bioflag Group and Postbiotics Inc. further underscore the dynamism of market entry and the innovative potential within the field.

Other notable entities including Beekeeper's Naturals, Inc., Dr. Emil Nutrition, LLC, DSM-Firmenich AG, and Essential Formulas Incorporated have adopted forward-thinking strategies that integrate customer education, extensive R&D, and strategic partnerships. Companies such as GeneFerm Biotechnology Co., Ltd. and Gundry MD have successfully bridged the gap between scientific research and consumer relevance through targeted product offerings.

Further, industry visionaries such as GutArmor by Get Wellness, LLC, Healist Naturals, LLC, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC and Kirin Holdings Company, Limited, have propelled the demand for postbiotics by aligning their research insights with robust manufacturing processes. Luxury champions like L'Oreal S.A. and innovative consortiums including Maypro Group, MCLS Europe B.V., and MRM Nutrition contribute to setting high industry standards.

The involvement of Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Probiotics Australia Pty., Ltd., Probioway Co., Ltd., and Puratos Group further reinforces the role of strategic collaborations and technologically advanced production methodologies. The market sees additional momentum from key players like Sabinsa Corporation, Silab SA, woresan GmbH, and POSTBIOTICA S.R.L., each of which is driving improvements in product performance and market accessibility. Collectively, these companies are not merely participants but rather pioneers in redefining health and wellness with scientifically substantiated postbiotic applications.

The report delves into recent significant developments in the Postbiotics Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Beekeeper's Naturals, Inc., Bioflag Group, Cargill Incorporated, Dr. Emil Nutrition, LLC, DSM-Firmenich AG, Essential Formulas Incorporated, GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, Healist Naturals, LLC, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, Kirin Holdings Company, Limited, L'Oreal S.A., Maypro Group, MCLS Europe B.V., MRM Nutrition, Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., Puratos Group, Sabinsa Corporation, Silab SA, woresan GmbH, and POSTBIOTICA S.R.L.. Actionable Suggestions for Navigating Market Dynamics

To effectively leverage emerging opportunities in the postbiotics market, industry leaders should adopt strategies that emphasize research, innovation, and consumer-centric product development. First, capitalizing on data-driven insights is crucial. Companies are encouraged to invest in advanced research and technology that can unravel the complex interactions of postbiotics with various biological systems. Enhanced data analytics can provide invaluable information that drives not only product improvement but also precise market positioning.

Moreover, maintaining a flexible and anticipatory approach to regulatory changes can safeguard operations while ensuring that products meet evolving quality and safety standards. Partnerships with research institutions, health experts, and regulatory bodies can bridge knowledge gaps and orient product strategies towards sustainable growth. Adapting and refining supply chain processes to improve production efficiency without compromising quality is another critical recommendation.

A key strategy should also involve comprehensive market segmentation analysis. Understanding the uniqueness of each segmentation by product type, formulation, functionality, packaging, application, end-user, and distribution channel can empower companies to tailor their marketing and production strategies. This granularity allows firms to anticipate consumer needs and respond swiftly to market trends.

Lastly, it is essential to build and nurture strong brand narratives that resonate with an increasingly health-conscious public. Emphasizing the scientific basis of postbiotic interventions, while also highlighting their tangible benefits, will secure consumer trust and foster brand loyalty over time.

Synthesis and Forward Outlook

In summary, the postbiotics market is positioned at the intersection of innovative science and a robust demand for advanced health solutions. Effective segmentation across multiple vectors has refined our understanding of both product diversity and consumer requirements, thereby enabling targeted strategies that can fuel market growth across global regions. Industry leaders are now tasked with not only adapting to a dynamic competitive environment but also ushering in new standards of product efficacy and reliability.

The evolution of this market is a direct consequence of persistent scientific innovations and a strategic emphasis on evidence-based product development. With region-specific insights and a well-mapped competitive landscape, the foundations are firmly in place for firms to capitalize on postbiotic opportunities. As the science continues to unveil new benefits and applications, adaptability and forward-thinking strategies will remain the cornerstones of market success.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing consumer awareness of gut health and its impact on overall well-being
    • 5.1.1.2. Rising preference for natural and functional ingredients globally
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with high production costs and limited commercial availability of postbiotics
  • 5.1.3. Opportunities
    • 5.1.3.1. Partnering with pharmaceutical companies to develop postbiotic formulations for digestive health
    • 5.1.3.2. Integrating postbiotics into skincare to attract consumers seeking innovative cosmetic products
  • 5.1.4. Challenges
    • 5.1.4.1. Understanding regulatory hurdles and gaining market approvals is a crucial challenge for postbiotics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type : High preference for capsules due to their convenience and precise dosages
  • 5.2.2. Application : Rise in the usage of probiotic supplements owing to increasing self-medication trends and preventive healthcare approaches
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Postbiotics Market, by Product Type

• 6.1. Introduction
• 6.2. Capsules
• 6.3. Liquids
  • 6.3.1. Concentrated Liquids
  • 6.3.2. Ready-To-Drink Liquids
• 6.4. Powders
• 6.5. Tablets
  • 6.5.1. Chewable Tablets
  • 6.5.2. Effervescent Tablets

7. Postbiotics Market, by Formulation

• 7.1. Introduction
• 7.2. Encapsulated
• 7.3. Unencapsulated

8. Postbiotics Market, by Functionality

• 8.1. Introduction
• 8.2. Digestive Health
• 8.3. Immune Support
• 8.4. Skin Health
• 8.5. Weight Management

9. Postbiotics Market, by Packaging Type

• 9.1. Introduction
• 9.2. Bottles
  • 9.2.1. Glass Bottles
  • 9.2.2. Plastic Bottles
• 9.3. Sachets
  • 9.3.1. Multi-Serving Sachets
  • 9.3.2. Single Use Sachets
• 9.4. Stick Packs

10. Postbiotics Market, by Application

• 10.1. Introduction
• 10.2. Animal Feed
• 10.3. Food & Beverages
• 10.4. Personal Care
• 10.5. Pharmaceuticals
  • 10.5.1. Medicine Drug Formulation
  • 10.5.2. Probiotic Supplements

11. Postbiotics Market, by End-User

• 11.1. Introduction
• 11.2. Adults
• 11.3. Geriatrics
• 11.4. Pediatrics

12. Postbiotics Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Online Stores
  • 12.2.1. E-commerce Websites
  • 12.2.2. Subscription Services
• 12.3. Pharmacies & Drug Stores
• 12.4. Specialty Stores
  • 12.4.1. Dietary Supplement Stores
  • 12.4.2. Health Food Stores
• 12.5. Supermarkets & Hypermarkets
  • 12.5.1. General Health Sections
  • 12.5.2. Organic Health Sections

13. Americas Postbiotics Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Postbiotics Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Postbiotics Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Innovative ResM GLP-1 postbiotic harnesses physician-developed science to refine the Gut-X Axis and advance metabolic balance
  • 16.3.2. Sabinsa and Postbiotics Inc. established a multinational distribution agreement for PoZibio
  • 16.3.3. Sirio Pharma's launches GummiBiotics
  • 16.3.4. Kerry Group introduces Plenibiotic, a novel rice-derived postbiotic to enhance digestive and skin health for humans and pets
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Archer-Daniels-Midland Company
• 2. Beekeeper's Naturals, Inc.
• 3. Bioflag Group
• 4. Cargill Incorporated
• 5. Dr. Emil Nutrition, LLC
• 6. DSM-Firmenich AG
• 7. Essential Formulas Incorporated
• 8. GeneFerm Biotechnology Co., Ltd.
• 9. Gundry MD
• 10. GutArmor by Get Wellness, LLC
• 11. Healist Naturals, LLC
• 12. Ildong Pharmaceutical Co., Ltd.
• 13. Kerry Group PLC
• 14. Kirin Holdings Company, Limited
• 15. L'Oreal S.A.
• 16. Maypro Group
• 17. MCLS Europe B.V.
• 18. MRM Nutrition
• 19. Otemchi Biotechnologies Pte. Ltd.
• 20. Phileo by Lesaffre
• 21. Postbiotics Inc.
• 22. Probiotics Australia Pty., Ltd.
• 23. Probioway Co., Ltd.
• 24. Puratos Group
• 25. Sabinsa Corporation
• 26. Silab SA
• 27. woresan GmbH
• 28. POSTBIOTICA S.R.L.